Skip to main content
Veterinary Research Forum logoLink to Veterinary Research Forum
. 2012 Autumn;3(4):251–255.

Comparison of the effects of fresh leaf and peel extracts of walnut (Juglans regia L.) on blood glucose and β-cells of streptozotocin-induced diabetic rats

Somaye Javidanpour 1, Seyed Reza Fatemi Tabtabaei 1,*, Amir Siahpoosh 2, Hasan Morovati 1, Ali Shahriari 1
PMCID: PMC4313044  PMID: 25653767

Abstract

There is some report about the hypoglycemic effect of Juglans rejia L. leaf in alloxan induced diabetic rats and hypoglycemic effect of its fruit peel administered intra peritoneally. Thirty male Wistar rats divided into five groups, to evaluate the hypoglycemic and pancreas β-cells regenerative effects of oral methanolic extracts of leaf and fruit peel of walnut. Rats were made diabetic by intravenous (IV) injection of 50 mg kg-1 streptozotocin (STZ). Negative control group did not get STZ and any treatment. Positive control, leaf extract, peel extract and insulin groups were treated orally by extract solvent, 200 mg kg-1 leaf extract, 200 mg kg-1 peel extract and 5 IU kg-1 of subcutaneous neutral protamine Hagedorn (NPH) insulin, respectively. Four weeks later, blood was collected for biochemical analysis and pancreases were removed for β-cells counts in histological sections. Diabetes leads to increase of fast blood sugar (FBS) and HbA1c, and decrease of β-cell number and insulin. FBS decreased only in leaf extract group. HbA1c decreased in leaf extract and insulin groups. The β-cells number increased in leaf and peel extract groups. Insulin increased moderately in all treatment groups. We showed the proliferative properties of leaves and peel of Juglans regia L. methanolic extract in STZ- induced diabetic rats, which was accompanied by hypoglycemic effect of leaf extract.

Key Words: Diabetes, Walnut leaf, Walnut peel, Hypoglycemia, Insulin

Introduction

Diabetes mellitus is a metabolic disease characterized by hyperglycemia together with impaired metabolism of glucose and other energy-yielding fuels, like lipids and proteins.1 These metabolic disorders are the result of insulin deficiency or tissue insulin resistance, or both.2 More than 220 million people worldwide suffer from diabetes and this number is likely double by the year of 2030.3

Walnut (Juglans regia) is a plant in the family Juglandaceae.4 Useful parts of walnut tree are leaves, second peel and fleshy part of green fruit and its wood.5 Green peel of walnuts fruit, epicarp contains emulsion, glucose, organic acids such as citric acid, malic acid, phosphates, and calcium oxalate. Other materials in its green peel are siaresinolic acid, betulinic acid, daucosterin, α-tetralone, α-glucopyranoside.6,7 Juglon is a 5-Hydroxy 1, 4-naphtoquinone that there is only in green and fresh parts of walnut and it is one of the most important phenolic compounds of walnut leaves and its green peel.8, 9

Juglans regia L. has been widely used in Iranian traditional medicine as a remedy for various ailments. Different parts of Juglans regia L. such as peel, leaves and septum have shown significant hypoglycemic effects.10 For example, hydroalcoholic extract of Juglans regia’s leaves has an anti-hyperglycemic effect in diabetic rats.11 Walnut (Juglans regia L.) leaves have also been used for treatment of venous insufficiency and hemorrhoidal symptomatology, and for its antidiarrheic, antihelmintic, depurative and astringent properties.12-14 Keratolytic, antifungal, hypotensive, anti-scrofulous and sedative activities have also been described.15,16 Walnut peels, similar to the walnut leaf have some antioxidant,17 antifungal,18,19 astringent, and wart liquidator properties used for skin diseases and anemia.20

Although there are some reports indicating the regenerative effect of walnut leaves extract on β-cells number and the size of pancreatic islet in alloxan-induced diabetic rats,21, 22 we could not find any report in STZ-induced diabetic animals. However, there were few studies that have examined the effects of IP administration of walnut peel extract in the diabetics,23,24 but there was no study testing the oral effects of walnut peel extract in the diabetic rats. In the present study we have reported the effect of the methanolic extract of leaves and peels of Juglans regia L. on the regeneration of β-cells and insulin level in STZ-induced diabetic rats, which provides interesting finding regarding the walnut leaves and the peel properties.

Materials and Methods

Extract preparation. Fresh ripe Walnuts and leaves of Juglans regia L. were collected from a garden near Eize (31°48'N, 049°54'E; the South-West of Iran) and were authenticated by Department of Pharmacognosy (Faculty of Pharmacy, Ahvaz Jundishapur University of Medical Sciences). The walnut fruits and leaves were cleaned and the green coat of the walnut fruits peeled. Peels and leaves were powdered by mill. Methanol was added to cover the surface of each powder. Seventy two hr later the solutions were filtered through filter paper. The peel extract was concentrated by rotary evaporator at 40 ˚C and lyophilized to get a powder. To overcome to it's rather insolubility the leaf extract was decanted by chloroform. Then the obtained extract was concentrated by rotary evaporator at 40 ˚C and dried.

Animals and specimen collection. Thirty male Wistar rats weighing 160-200 g were used in this study. Rats were kept in a room with a 12:12 hr light/dark cycle and controlled temperature (22 ± 1 ˚C). Commercial rat pellets and tap water were available ad libitum. They were allowed to adapt to the laboratory conditions for one week before the study.25 Diabetes was induced by IV injection of STZ (Alexis Corporation, Switzerland; 50 mg kg-1) dissolved in 0.1 M citrate buffer (pH=4.5). Negative control group received equal volume of citrate buffer, with no manipulation during the study. One week later, the FBS of negative control and diabetic animals were measured by commercial glucose kit (Parsazmun, Karaj, Iran). Survived rats with marked hyperglycemia (FBS > 300 mg dL-1) were selected as diabetic rats, divided into 4 diabetic groups. A solution of distilled water and propylene glycol (3/2: v/v) was used to dissolve the extracts. Positive control group, peel extract group and leaf extract group were fed through a tube with daily administration 2 mg kg-1 of extract solvent, 200 mg kg-1 of peel extract and 200 mg kg-1 of leaf extract,21, 26 respectively. Insulin group treated with daily SC injection of 5 IU kg-1 of neutral protamine Hagedorn (NPH) insulin.27

Twenty eight days after diabetes confirmation, animals were anesthetized deeply by chloroform (Merck Darmstadt, Germany) vapor and blood was taken from their heart. They were subsequently euthanized under chloroform vapor. Pancreases were fixed in 10% formalin. Blood samples were transferred to EDTA containing tube, 500 μL removed for measurement of glycosylated hemoglobin (HbA1c) and the reminder was centrifuged at 3000 rpm for 15 min to separate plasma for glucose and insulin measurement.

Biochemical parameters. Serum glucose was measured by GOD/POD method (Diagnostic kit: Pars-azmun, Karaj-Iran) using a visible spectrophotometer at 546 nm. Glycated hemoglobin (HbA1c) was determined by diagnostic kit (Costa Brava 30, Barcelona, Spain). Insulin was measured by ultra-sensitive rat ELISA kit (Mercodia, Uppsala-Sweden).

Tissue processing and β-cells count. Pancreases were fixed in 10% formalin, and 3-5 μm thick sections were prepared by the routine methods and stained with Hematoxylin and Eosin (H&E). Cells with small and dark nuclei considered as β-cells and cells with large and clear nuclei as α-cells. Three slides were prepared form each samples. The β-cells in each slide were counted in three fields with 400× magnification. Thus, each sample of pancreases was counted in 9 fields. Finally, the mean number of β-cells in nine fields was considered as the β-cells number of pancreases in each rat.

Statistical analysis. Data were analyzed by SPSS (version 16 for windows, SPSS Inc., Chicago, IL, USA) and expressed as mean ± standard error of mean (SEM). Statistical evaluation was done using one-way analysis of variance (ANOVA) followed by Tukey’s test to analyze the differences between the groups. The data obtained from FBS test were analyzed using paired sample t-test. A p-value less than 0.05 was considered significant.

Results

Induction of diabetes increased FBS (p < 0.001) and HbA1c (p < 0.001) of positive control group (Table 1). The leaf extract significantly decreased glucose level (p < 0.05) and HBA1c (p = 0.001). There was no significant decrease in FBS of peel extract and insulin groups compared to pretreatment level, but HbA1c significantly decreased in insulin group (p < 0.05).

Table 1.

Effect of methanolic extract of leaves and peels of walnut (Juglans regia L.) on FBS, HbA1c, β-cell number and plasma insulin level (Mean ± SEM).

Group FBS (mg dL -1 )
HbA1c (%) Number of β-ells per counted field Insulin (ng L -1 )
Day 0 Day 28
Insulin 417.80 ± 61.50 c 372.80 ± 32.70 b 7.49 ± 0.48 b 59.00 ± 5.00 b 535.00 ± 122.00 ab
Negative control 93.30 ± 3.60 a 108.10 ± 5.60 a 5.02 ± 0.42 a 88.00 ± 5.00 c 930.00 ± 35.00 b
Positive control 368.20 ± 26.90 bc 405.50 ± 41.50 b 9.72 ± 0.35 c 37.00 ± 5.00 a 224.00 ± 43.00 a
Leaf extract 403.00 ± 62.10 c 283.80 ± 52.20 ab* 6.64 ± 0.68 ab 72.00 ± 7.00 bc 539.00 ± 143.00 ab
Peel extract 421.10 ± 41.90 c 359.60 ± 43.90 b 8.38 ± 0.38 bc 80.00 ± 9.00 c 461.00 ± 160.00 ab
a,b,c

different letters indicate significant differences between groups (p < 0.05).

*

indicate significant differences as compared to pre-treatment level (p < 0.05).

Figure 1A indicate a normal islet of Langerhans from negative control group. Beta cell number reduced dramatically in the positive control group (p < 0.001) (Fig. 1B) and moderately in insulin group (p < 0.05) (Fig. 1E), but it increased in leaf extract (p < 0.05) and the peel extract (p < 0.001) groups (Figs. 1C and 1D) in comparison to positive control groups. The insulin level reduction was only significant in positive control group (p < 0.01).

Fig. 1.

Fig. 1

Histological sections of pancreas. A. An islet of Langerhans from negative control rat pancreas occupies the center of the field (yellow arrow) B. An islet of Langerhans from pancreas of diabetic rat (yellow arrow) C. Two islets of Langerhans from pancreas of diabetic rat, treated with walnut peel extract (yellow arrows). D. Two islets of Langerhans from pancreas of diabetic rat treated with walnut leaf extract (yellow arrows). E. An islet of Langerhans from pancreas of diabetic rat treated with NPH insulin (yellow arrows) (H & E 200×).

Discussion

The hypoglycemic activity of walnut leaves has been reported by previous studies.10, 21, 22 At the present study, diabetes increased FBS and HbA1c and decreased pancreatic β-cells and plasma insulin. Administration of leaves extract significantly decreased FBS and HbA1c of diabetic animals. Both extracts increased the number of β-cells in diabetic groups, but there was no significant difference in the level of plasma insulin of leaf extract, peel extract and insulin groups in comparison with negative control and diabetic groups.

Hypoglycemic effect of plants may be due to stimulation of β-cells to produce more insulin,28, 29 increasing glucose metabolism,30 improving insulin action and binding carbohydrate28 with high level of fiber which interfere with carbohydrate absorption,31 presence of insulin-like substances in plants32,33 and/or regenerative effect of plants on pancreatic tissue.34 Teimori et al. reported that the methanolic extract of walnut leaf inhibited α-glucosidase activity in vitro for both maltase and sucrase enzymes.25 They did not find any significant increase in the insulin and glut-4 genes expression in the pancreatic and myocardial tissues, respectively.25 These findings are in accordance with the recent study, which we did not find any significant increase in the insulin level of leaf extracts treated group. However, Kamyab et al. showed 2 hr after treatment by both leaf and ridge hydroalcoholic extracts of walnut, blood glucose and liver gluconeogenic activity have decreased and blood insulin and liver glycogenolysis activity have increased in mild STZ-diabetic mice.35 They concluded that walnut was able to lower blood glucose through inhibition of hepatic gluconeogenesis and secretion of pancreatic insulin.35 The key compound responsible for inhibitory action of the leaf extract may be phenolic substances, such as gallic acid and caffeoylquinic acid.17 A flavonoid fraction extracted from the plant caused a decrease in blood glucose and an increase in β-cells.36

Level of HbA1c has been reported to increase in patients with diabetes mellitus.37 The level of HbA1c is always monitored as a reliable index of glycemic control in diabetes.38 The HbA1c level is proportional to average blood glucose concentration over the previous four weeks to three months.39 In our study, treatment of diabetic rats with the leaf extract and insulin significantly decreased the HbA1c level in comparison with the positive control group. Therefore, it was thought the hypoglycemic effect of leaf extract and insulin had begun from the beginning days of the treatments. It was suggested that herbal insulin-like substances in the walnut leaf might be responsible for the hypoglycemic properties of the walnut leaf.40 Despite the hypoglycemic effect of insulin and the reduction of HbA1c in the insulin treated group, no change was seen in the initial and final FBS of the insulin group. This is acceptable, because no treatment was done at least from 30 hr before specimen collection.

Although administration of the peel extract to diabetic rats had no significant effect on FBS and HbA1c level, but it increased the number of β-cells significantly compared to the positive control group. Green peel and leaves of walnut contain antioxidants such as flavonoides.17 Recent studies have shown the flavonoids could reduce blood sugar.10,41 The peel of walnut has been used in traditional medicine to reduce the blood glucose in diabetic patients.10 Increasing number the β-cells in peel extract group without changes in FBS and HbA1c level might be related to the dysfunctional β-cells unable to produce enough insulin or produce suitable response to glucose elevation. If the duration of the experiment was longer may led to reduction of FBS and HbA1c by increasing β-cell responsiveness and insulin secretion. The leaves and peel of walnut may have some protective and regenerative effect on β-cells.

In conclusion, according to the results of this study methanolic extract of fresh walnut leaves have significant hypoglycemic properties, which might be related to its insulinomimetic, insulinotropic and/or β-cells regenerative effect of the extract in STZ-diabetic rats. Methanolic extract of fresh walnut peel extract increased β-cells regeneration after 28 days treatment of STZ- diabetic rats. This may be the first report emphasis the proliferative effects of walnut peel on β-cells of diabetic rats and proliferative effects of walnut leaf on STZ treated islets.

Acknowledgment

We offer our thanks to Shahid Chamran University of Ahvaz for its financial support. This paper was obtained from Master's thesis of Shahid Chamran University.

References

  • 1.Scheen JA. Drug treatment of non-insulin dependent diabetes mellitus in the 1990s. Achievements and future development. Drugs. 1997;54:355–368. doi: 10.2165/00003495-199754030-00001. [DOI] [PubMed] [Google Scholar]
  • 2.Vinik AI, Vinik E. Prevention of the complications of diabetes. Am J Manag Care. 2003;9(3 Suppl.):63–80. [PubMed] [Google Scholar]
  • 3.Boyle JP, Honeycutt AA, Arayan KM, et al. Projection of diabetes burden through 2050: Impact of changing demography and disease prevalence in the US. Diabetes Care. 2001;24:1936–1940. doi: 10.2337/diacare.24.11.1936. [DOI] [PubMed] [Google Scholar]
  • 4.Mabberley DJ. The Plant Book. Cambridge, MA: Cambridge University Press ; 1993. p. 301. [Google Scholar]
  • 5.Pereira JA, Oliveira I, Sousa A, et al. Bioactive properties and chemical composition of six walnut (Juglans regia L ) cultivars. . Food Chem Toxicol. 2008;46:2103–2111. doi: 10.1016/j.fct.2008.02.002. [DOI] [PubMed] [Google Scholar]
  • 6.Savage GP. Chemical composition of walnuts (Juglans regia L ) grown in New Zealand. . Plant Food Hum Nutrition. 2001;56:75–82. doi: 10.1023/a:1008175606698. [DOI] [PubMed] [Google Scholar]
  • 7.Sze-Tao KW, Sathe SK. Walnuts (Juglans regia L ): proximate composition, protein solubility, protein amino acid composition and protein in vitro digestibility. . J Sci Food Agric. 2000;80:1393–1401. [Google Scholar]
  • 8.Jaimand K, Baghai P, Rezaee MB, et al. Determination of Juglone from leaves and fresh peels of Juglans regia L by high performance liquid chromatography. . Iranian J Med Arom Plants Res. 2004;20:323–331. [Google Scholar]
  • 9.Cosmolescu S, Trandafir I, Achim GH, et al. Phenolics of green husk in mature walnut fruits. Not Bot Hort Agrobot Cluj. 2010;38:53–56. [Google Scholar]
  • 10.Zargari A. Medicinal plants. 4th vol. Tehran: Tehran university press; 1997. pp. 325–328. [Google Scholar]
  • 11.Sarahroodi S, Rasekh HR, Kamalinejad M, et al. Glucose lowering effect of the water extract of septum of Juglans regia L (Persian Walnut) fruit in male rats. . Pharmacogn Mag. 2008;14:109–113. [Google Scholar]
  • 12.Wichtl M, Anton R. Plantes therapeutiques. Paris: Technique et Documentation ; 1999. pp. 291–293. [Google Scholar]
  • 13.Van Hellemont J. Compendium de phytotherapie. Bruxelles: Association Pharmaceutique Belge ; 1986. pp. 214–216. [Google Scholar]
  • 14.Bruneton J. Pharmacogosie, phytochimie, plantes medicinales. Paris: Technique et Documentation - Lavoisier ; 1993. p. 348. [Google Scholar]
  • 15.Girzu M, Carnat A, Privat AM, et al. Sedative effect of walnut leaf extract and juglone, an isolated constituent. Pharm Biol. 1998;36(4):280–286. [Google Scholar]
  • 16.Valnet J. Phytoth erapie treatment of diseases by plants. Paris: Maloine ; 1992. pp. 476–478. [Google Scholar]
  • 17.Pereira JA, Oliveira I, Sousa A, et al. Walnut (Juglans regia L.) leaves: Phenolic compounds, antibacterial activity and antioxidant potential of different cultivars. Food Chem Toxicol. 2007;45:2287–2295. doi: 10.1016/j.fct.2007.06.004. [DOI] [PubMed] [Google Scholar]
  • 18.Ali-Shtayeh MS, Abu Ghdeib SI. Antifungal activity of plant extracts against dermatophytes. Mycoses. 1999;42:665–672. doi: 10.1046/j.1439-0507.1999.00499.x. [DOI] [PubMed] [Google Scholar]
  • 19.Noumi E, Snoussi M, Hajlaoui H, et al. Antifungal propertiesof Salvadora persica and Juglans regia L extracts against oral Candida strains. . Eur J Clin Microbiol Infect Dis. 2010;29:81–88. doi: 10.1007/s10096-009-0824-3. [DOI] [PubMed] [Google Scholar]
  • 20.Erdemoglu N, Kupeli E, Yesilada E. Anti-inflammatory and antinociceptive assessment of plants used as remedy in Turkish folk medicine. J Ethnopharmacol. 2003;89:123–129. doi: 10.1016/s0378-8741(03)00282-4. [DOI] [PubMed] [Google Scholar]
  • 21.Asgary S, Parkhideh S, Solhpour A, et al. Effect of ethanolic extract of Juglans regia L on blood sugar in diabetes-induced rats. . J Med Food. 2008;11:533–538. doi: 10.1089/jmf.2007.0611. [DOI] [PubMed] [Google Scholar]
  • 22.Jelodar G, Maleki M, Shahram S. Effect of walnut leaf, coriander and pomegranate on blood glucose and histopathology of pancreas of alloxan induced diabetic rats. Afr J Tradit Complement Altern Med. 2007;4:299–305. doi: 10.4314/ajtcam.v4i3.31223. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Kavalah G, Tuncel H, Goksel S, et al. Hypoglycemic activity of Juglans regia L on streptozotocin diabetic rats. Acta Pharm Turc. 2002;44:243–248. [Google Scholar]
  • 24.Mirbadalzadeh R, Shirdel Z. Evaluation of the blood glucose reducing effects of walnut green husk extract in diabetic rats. Int J Pharm Sci Rev Res. 2010;5:145–147. [Google Scholar]
  • 25.Teimori M, Montasser Kouhsari S, Ghafarzadegan R, et al. Study of hypoglycemic effect of juglans regia leaves and its mechanism. J Med Plants. 2010:57–65. [Google Scholar]
  • 26.Mohammadi J, Saadipour K, Delaviz H, et al. Anti-diabetic effects of an alcoholic extract of Juglans regia in an animal model. J Med Sci. 2011;41:685–691. [Google Scholar]
  • 27.Tedong L, Dimo T, Dzeufiet PD, et al. Antihyper-glycemic and renal protective activities of Anacardium Occidentale (Anacardiaceae) leaves in streptozotocin induced diabetic rats. Afr J Trad Comp Alt Med. 2006;3(1):23–35. [Google Scholar]
  • 28.Khan A, Bryden NA, Polasky MN, et al. Insulin potentiating factor and chromium content of selected spices. Biol Trace Elem Res. 1990;24:183–188. doi: 10.1007/BF02917206. [DOI] [PubMed] [Google Scholar]
  • 29.Chang MW, Johnson MA. Effect of garlic on carbohydrate metabolism and lipid synthesis in rats. J Nutr. 1980;110:931–936. doi: 10.1093/jn/110.5.931. [DOI] [PubMed] [Google Scholar]
  • 30.Broadhurst CL. Nutrition and non-insulin dependent diabetes mellitus from an anthropological perspective. Altern Med Rev. 1997;25:378–399. [Google Scholar]
  • 31.Nelson RW, Ihle SL, Lewis LD, et al. Effects of dietary fiber supplementation on glycemic control in dogs with alloxan-induced diabetes mellitus. Am J Vet Res. 1991;52:2060–2066. [PubMed] [Google Scholar]
  • 32.Collier E, Watkinson A, Cleland CF, et al. Partial purification and characterization of an insulin-like material from spinach and lemna gibba G3. J Biol Chem. 1987;262:6238–6241. [PubMed] [Google Scholar]
  • 33.Gray AM, Flatt PR. Insulin-releasing and insulin-like activity of the traditional anti-diabetic plant Coriandrum sativum (coriander) Br J Nutr. 1999;8:203–208. doi: 10.1017/s0007114599000392. [DOI] [PubMed] [Google Scholar]
  • 34.Shanmugasundaram ER, Gopith KL, Radha SK, et al. Possible regeneration of the islets of Langerhans in streptozotocin-diabetic rats given Gymnema sylvestere leaf extract. J Ethnopharmacol . 1990;30:265–269. doi: 10.1016/0378-8741(90)90106-4. [DOI] [PubMed] [Google Scholar]
  • 35.Kamyab H, Hejrat S, Khanavi M, et al. Hepatic mechanisms of the walnut antidiabetic effect in mice. J Biol. 2010;5:304–309. [Google Scholar]
  • 36.Chakravarthy BK, Gupta S, Gambhir SS, et al. Pancreatic beta cell regeneration: A novel antidiabetic mechanism of Petercarpus marsupium. Indian J Pharma. 1980;12:123–128. [Google Scholar]
  • 37.Paulsen EP. Hemoglobin A1C in childhood of diabetes. Metabolism. 1993;22:269–271. doi: 10.1016/0026-0495(73)90170-4. [DOI] [PubMed] [Google Scholar]
  • 38.Gabbay KH. Glycosylated hemoglobin and diabetic control. New Engl J Med. 1976;95:443–454. doi: 10.1056/NEJM197608192950810. [DOI] [PubMed] [Google Scholar]
  • 39.Chandrashekar MS, Deepa K, Vijay Kumar S. Comprehensive review on HbA1c in diagnosis of diabetes melitus. Inter J Pharma Sci Rev Res. 2010;3:119–122. [Google Scholar]
  • 40.Jelodar G, Nazifi S. Study of effect extracts of walnut leaf on some biochemical parameters in diabetic rats. Shahid beheshti J. 1999;2:18–25. [Google Scholar]
  • 41.Vaya J, Viram A. Nutritional antioxidants: Mechanism of action, analyses of activities and medical applications. Curr Med Chem Immunol Endocr Metab Agents. 2002;1:99–117. [Google Scholar]

Articles from Veterinary Research Forum are provided here courtesy of Faculty of Veterinary Medicine, Urmia University, Urmia, Iran

RESOURCES